Earnings calendar/ORKA
Oruka Therapeutics, Inc. (ORKA)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 11, 2026
Consensus estimate row
EPS target
$-0.59
Street estimate
Revenue target
—
Street estimate
Trailing EPS (avg 4Q)
$-0.51
Beat rate last 4: 75%
Latest EPS YoY
-19.6%
vs 2025-08-11
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 10, 2026
EPS miss
EPS actual / est
$-0.55 / $-0.51
-7.3%
Revenue actual / est
— / —
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/11/2026upcoming | $-0.59 | Pending | — | — | Pending | — |
| 8/10/2026 | $-0.51 | $-0.55 | -7.3% | — | Pending | — |
| 5/13/2026 | $-0.55 | $-0.48 | +12.2% | — | Pending | — |
| 3/16/2026upcoming | $-0.62 | Pending | — | — | Pending | — |
| 3/12/2026 | $-0.61 | $-0.45 | +26.2% | — | Pending | — |
| 3/9/2026upcoming | $-0.62 | Pending | — | — | Pending | — |
| 3/5/2026upcoming | $-0.61 | Pending | — | — | Pending | — |
| 11/12/2025 | $-0.56 | $-0.55 | +1.8% | — | Pending | — |
| 8/11/2025 | $-0.48 | $-0.46 | +4.2% | — | Pending | — |
| 5/14/2025 | $-0.57 | $-0.40 | +29.8% | — | Pending | — |
| 3/6/2025 | $-0.68 | $-0.49 | +27.9% | — | Pending | — |
| 2/27/2025 | $-0.68 | $-0.96 | -41.2% | — | Pending | — |
| 11/13/2024 | $-0.40 | $-1.46 | -265.0% | — | Pending | — |
| 8/27/2024 | — | $-1.88 | — | — | Pending | — |
| 8/1/2024 | — | $-0.76 | — | — | Pending | — |
| 4/25/2024 | — | $-0.14 | — | — | Pending | — |
| 12/31/2023 | — | $-0.08 | — | — | Pending | — |
| 12/30/2023 | — | $-0.08 | — | — | Pending | — |
| 9/30/2023 | — | $-0.10 | — | — | Pending | — |
| 6/30/2023 | — | $-0.10 | — | — | Pending | — |
| 3/31/2023 | — | $-0.09 | — | — | Pending | — |
| 12/31/2022 | — | $-0.98 | — | — | Pending | — |
| 9/30/2022 | — | $-1.94 | — | — | Pending | — |
| 6/30/2022 | — | $-2.62 | — | — | Pending | — |
| 3/31/2022 | — | $-2.72 | — | — | Pending | — |
| 12/31/2021 | $-26.88 | $-4.73 | +82.4% | — | Pending | — |
| 9/30/2021 | $-27.60 | $-3.92 | +85.8% | — | Pending | — |
| 6/30/2021 | $-28.44 | $-4.03 | +85.8% | — | Pending | — |
| 3/31/2021 | $-22.44 | $-3.98 | +82.3% | — | Pending | — |
| 12/31/2020 | — | $-6.44 | — | — | Pending | — |
| 9/30/2020 | — | $-3.95 | — | — | Pending | — |
| 6/30/2020 | — | $-8.71 | — | — | Pending | — |
| 3/31/2020 | — | $-9.94 | — | — | Pending | — |
| 12/31/2019 | — | $-9.23 | — | — | Pending | — |
| 9/30/2019 | — | $-9.12 | — | — | Pending | — |
| 6/30/2019 | — | $-13.64 | — | — | Pending | — |
| 3/31/2019 | — | $-22.29 | — | — | Pending | — |
| 12/31/2018 | — | $-23.10 | — | — | Pending | — |
| 9/30/2018 | — | $-24.71 | — | — | Pending | — |
| 6/30/2018 | — | $-32.83 | — | — | Pending | — |
| 3/31/2018 | — | $-43.37 | — | — | Pending | — |
| 12/31/2017 | — | $-76.99 | — | — | Pending | — |
| 9/30/2017 | — | $-83.24 | — | — | Pending | — |
| 6/30/2017 | — | $-127.91 | — | — | Pending | — |
| 3/31/2017 | — | $-103.03 | — | — | Pending | — |
Need ORKA data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.